Efficacy of imiquimod 3.75% from Lmax according to the number of actinic keratosis lesions

Ketty Peris; E. Stockfleth; G. Gupta; S. Aractingi; R. Dakovic; T. Dirschka; A. Alomar

doi:10.1111/jdv.12782

Efficacy of imiquimod 3.75% from Lmax according to the number of actinic keratosis lesions

Ketty Peris, E. Stockfleth, G. Gupta, S. Aractingi, R. Dakovic, T. Dirschka, A. Alomar

Risultato della ricerca: Contributo in rivista › Articolo

10 Citazioni (Scopus)

Abstract

Imiquimod 3.75% reduces 92.2% of all actinic keratosis (AK) lesions, assumed to include both subclinical and clinical lesions, across a large sun-exposed field such as the full face or balding scalp.

Lingua originale	Inglese
pagine (da-a)	2470-2473
Numero di pagine	4
Rivista	Journal of the European Academy of Dermatology and Venereology
Volume	2015
DOI	https://doi.org/10.1111/jdv.12782
Stato di pubblicazione	Pubblicato - 2015

Keywords

actinic keratosis

Accesso al documento

10.1111/jdv.12782

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{2158190eda54444b98d5d43a7eacebaf,

title = "Efficacy of imiquimod 3.75\% from Lmax according to the number of actinic keratosis lesions",

abstract = "Imiquimod 3.75\% reduces 92.2\% of all actinic keratosis (AK) lesions, assumed to include both subclinical and clinical lesions, across a large sun-exposed field such as the full face or balding scalp.",

keywords = "actinic keratosis, actinic keratosis",

author = "Ketty Peris and E. Stockfleth and G. Gupta and S. Aractingi and R. Dakovic and T. Dirschka and A. Alomar",

year = "2015",

doi = "10.1111/jdv.12782",

language = "English",

volume = "2015",

pages = "2470--2473",

journal = "Journal of the European Academy of Dermatology and Venereology",

issn = "0926-9959",

publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - Efficacy of imiquimod 3.75% from Lmax according to the number of actinic keratosis lesions

AU - Peris, Ketty

AU - Stockfleth, E.

AU - Gupta, G.

AU - Aractingi, S.

AU - Dakovic, R.

AU - Dirschka, T.

AU - Alomar, A.

PY - 2015

Y1 - 2015

N2 - Imiquimod 3.75% reduces 92.2% of all actinic keratosis (AK) lesions, assumed to include both subclinical and clinical lesions, across a large sun-exposed field such as the full face or balding scalp.

AB - Imiquimod 3.75% reduces 92.2% of all actinic keratosis (AK) lesions, assumed to include both subclinical and clinical lesions, across a large sun-exposed field such as the full face or balding scalp.

KW - actinic keratosis

UR - http://hdl.handle.net/10807/60876

U2 - 10.1111/jdv.12782

DO - 10.1111/jdv.12782

M3 - Article

SN - 0926-9959

VL - 2015

SP - 2470

EP - 2473

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

ER -

Efficacy of imiquimod 3.75% from Lmax according to the number of actinic keratosis lesions

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo